5W5Q
MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-yn-1-yl)-6,7-dihydro-5H-5,7-methanobenzo[c]imidazo[1,2-a]azepine-2,3-dicarboxamide)
5W5Q の概要
エントリーDOI | 10.2210/pdb5w5q/pdb |
分子名称 | Mitogen-activated protein kinase kinase kinase kinase 4, (5s,7s)-N~3~-methyl-10-[3-methyl-3-(5-methyl-1,3-oxazol-2-yl)but-1-yn-1-yl]-6,7-dihydro-5H-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide (3 entities in total) |
機能のキーワード | kinase, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 76183.65 |
構造登録者 | |
主引用文献 | Feng, J.A.,Lee, P.,Alaoui, M.H.,Barrett, K.,Castanedo, G.,Godemann, R.,McEwan, P.,Wang, X.,Wu, P.,Zhang, Y.,Harris, S.F.,Staben, S.T. Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1). Acs Med.Chem.Lett., 10:1260-1265, 2019 Cited by PubMed: 31531194DOI: 10.1021/acsmedchemlett.8b00658 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.33 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード